102897463
The FDA is expected to take another look at controversial diabetes drug Avandia after researchers at Duke have concluded the drug doesn't increase the risk of cardiovascular death as previously reported. - 

The FDA is expected to take another look at controversial diabetes drug Avandia after researchers at Duke have concluded the drug doesn't increase the risk of cardiovascular death as previously reported. But is it too little too late?

Shelter magazines are on the rebound as the housing industry bounces back. What other lateral signs are there out there?

Stocks are risky, but bonds are safe, or so goes the stereotype. Buy a solid bond -- the logic goes -- and you get your money back at maturity with interest. Then there are bond mutual funds, which are built on bonds, but are a very different animal than straight up bonds. As interest rates have risen over the past month, dividends for some of the nation's largest bond funds have been all but wiped out.

Follow David Brancaccio at @DavidBrancaccio